ClinicalTrials.Veeva

Find clinical trials for Kidney Disease in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
Renal Insufficiency
IGA Glomerulonephritis
Renal Cell Carcinoma
Diabetes Mellitus

Kidney Disease trials near Portland, OR, USA:

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:Eva...

Active, not recruiting
Secondary Hyperparathyroidism-Chronic Kidney Disease
Drug: Doxercalciferol (GZ427397)
Drug: Calcitriol

Phase 3

Sanofi
Sanofi

Portland, Oregon, United States and 29 other locations

Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...

Enrolling
Chronic Kidney Disease
Type 1 Diabetes Mellitus
Other: Placebo
Drug: Finerenone

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 80 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 141 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Placebo
Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 145 other locations

The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access

Active, not recruiting
End Stage Renal Disease
Vascular Access
Procedure: Arteriovenous fistula (AVF)
Biological: Human Acellular Vessel (HAV)

Phase 3

Humacyte
Humacyte

Portland, Oregon, United States and 30 other locations

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...

Enrolling
Chronic Kidney Disease
Cardiovascular Diseases
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Portland, Oregon, United States of America and 390 other locations

2 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug plus doxorubicin ve...

Active, not recruiting
Rhabdoid Tumors of the Kidney (RTK)
Selected Tumors With Rhabdoid Features
Drug: Tazemetostat

Phase 2

Epizyme

Portland, Oregon, United States and 31 other locations

of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) ...

Enrolling
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
Allogeneic Hematopoietic Cell Transplant
Biological: tabelecleucel

Phase 3

Atara Biotherapeutics

Portland, Oregon, United States and 70 other locations

This is a multicenter, international, three-part, Phase 1 study designed to evaluate the safety, tolerability, and PK of rising single doses of AT-02...

Enrolling
Amyloidosis; Systemic
Other: AT-02 (Placebo)
Drug: AT-02

Phase 1

Attralus

Portland, Oregon, United States and 10 other locations

All patients will receive IL-2 (14 planned doses with an additional cycle 14 days after the first). Responding patients with regressing disease...

Active, not recruiting
Renal Cell Carcinoma
Radiation: SBRT
Biological: High Dose IL-2

Phase 2

Providence Health & Services
Providence Health & Services

Portland, Oregon, United States

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems